COVID-19 Update: All AMP Locations are open, see how we are offering safe in person care and virtual visits. Click here to Learn more about Virtual Care Options.

Due to high call volume, you may experience hold times that are longer than usual.

Non-Discrimination Notice

A.M.P. is the first to enroll a patient in the eRadicate trial nation-wide!

Our Research department is pleased to announce that we are the FIRST clinical research department in the nation to enroll a patient in this new trial which can extend the life of a patient with prostate cancer by at least 9 months.

Please see further details on this trial: